Preliminary Assessment of a Telehealth Approach to Evaluating, Treating, and Discharging Low-Acuity Patients With Suspected COVID-19.


Journal

The Journal of emergency medicine
ISSN: 0736-4679
Titre abrégé: J Emerg Med
Pays: United States
ID NLM: 8412174

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 05 2020
revised: 21 07 2020
accepted: 02 08 2020
pubmed: 4 10 2020
medline: 5 1 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

Telemedicine is uniquely positioned to address challenges posed to emergency departments (EDs) by the Coronavirus Disease 2019 (COVID-19) pandemic. By reducing in-person contact, it should decrease provider risk of infection and preserve personal protective equipment (PPE). To describe and assess the early results of a novel telehealth workflow in which remote providers collaborate with in-person nursing to evaluate and discharge well-appearing, low-risk ED patients with suspected COVID-19 infection. Retrospective chart review was completed 3 weeks after implementation. Metrics include the number of patients evaluated, number of patients discharged without in-person contact, telehealth wait time and duration, collection of testing, ED length of stay (ED-LOS), 72-h return, number of in-person health care provider contacts, and associated PPE use. Among 302 patients evaluated by telehealth, 153 patients were evaluated and discharged by a telehealth provider with reductions in ED-LOS, PPE use, and close contact with health care personnel. These patients had a 62.5% shorter ED-LOS compared with other Emergency Severity Index level 4 patients seen over the same time period. Telehealth use for these 153 patients saved 413 sets of PPE. We observed a 3.9% 72-h revisit rate. One patient discharged after telehealth evaluation was hospitalized on a return visit 9 days later. Telehealth can be safely and efficiently used to evaluate, treat, test, and discharge ED patients suspected to have COVID-19. This workflow reduces infection risks to health care providers, PPE use, and ED-LOS. Additionally, it allows quarantined but otherwise well clinicians to continue working.

Sections du résumé

BACKGROUND
Telemedicine is uniquely positioned to address challenges posed to emergency departments (EDs) by the Coronavirus Disease 2019 (COVID-19) pandemic. By reducing in-person contact, it should decrease provider risk of infection and preserve personal protective equipment (PPE).
OBJECTIVES
To describe and assess the early results of a novel telehealth workflow in which remote providers collaborate with in-person nursing to evaluate and discharge well-appearing, low-risk ED patients with suspected COVID-19 infection.
METHODS
Retrospective chart review was completed 3 weeks after implementation. Metrics include the number of patients evaluated, number of patients discharged without in-person contact, telehealth wait time and duration, collection of testing, ED length of stay (ED-LOS), 72-h return, number of in-person health care provider contacts, and associated PPE use.
RESULTS
Among 302 patients evaluated by telehealth, 153 patients were evaluated and discharged by a telehealth provider with reductions in ED-LOS, PPE use, and close contact with health care personnel. These patients had a 62.5% shorter ED-LOS compared with other Emergency Severity Index level 4 patients seen over the same time period. Telehealth use for these 153 patients saved 413 sets of PPE. We observed a 3.9% 72-h revisit rate. One patient discharged after telehealth evaluation was hospitalized on a return visit 9 days later.
CONCLUSION
Telehealth can be safely and efficiently used to evaluate, treat, test, and discharge ED patients suspected to have COVID-19. This workflow reduces infection risks to health care providers, PPE use, and ED-LOS. Additionally, it allows quarantined but otherwise well clinicians to continue working.

Identifiants

pubmed: 33008664
pii: S0736-4679(20)30849-0
doi: 10.1016/j.jemermed.2020.08.007
pmc: PMC7413125
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

957-963

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Ann Emerg Med. 2018 May;71(5):555-563.e1
pubmed: 28967514
Am J Emerg Med. 2018 Nov;36(11):2061-2063
pubmed: 30209006
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855

Auteurs

David J Carlberg (DJ)

Department of Emergency Medicine, Georgetown University School of Medicine, Washington, DC; Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Rahul Bhat (R)

Department of Emergency Medicine, Georgetown University School of Medicine, Washington, DC; Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

William O Patterson (WO)

Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Saad Zaatari (S)

Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Vinodh Chandra (V)

Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Alexander Kolkin (A)

Georgetown Emergency Medicine Residency, MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Raj M Ratwani (RM)

Department of Emergency Medicine, Georgetown University School of Medicine, Washington, DC; Scientific Affairs, MedStar Health Research Institute, MedStar Health National Center for Human Factors in Healthcare, Washington, DC.

Matthew D Wilson (MD)

Department of Emergency Medicine, Georgetown University School of Medicine, Washington, DC; Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC; MedStar Georgetown University Hospital / MedStar Washington Hospital Center, Washington, DC.

Diana Ladkany (D)

Department of Emergency Medicine, Georgetown University School of Medicine, Washington, DC; MedStar Washington Hospital Center, Washington, DC; Department of Emergency Medicine, MedStar Harbor Hospital, Baltimore, MD.

Katharine T Adams (KT)

MedStar Health National Center for Human Factors in Healthcare, Washington, DC.

Mary Jackson (M)

MedStar Franklin Square Medical Center, MedStar Franklin Square Hospital, Baltimore, MD.

Kristi Lysen-Hendershot (K)

Project Management Office, MedStar Telehealth Innovation Center, MedStar Health, Washington, DC.

Ethan A Booker (EA)

MedStar Telehealth Innovation Center, MedStar Washington Hospital Center, Washington, DC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH